Vera Therapeutics, Inc. (VERA) stock
VERANasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.20−0.77 (-2.86%)
Close on Nov 17, 2026Market cap $1.89BP/E –Yield –
Vera Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Vera Therapeutics's price to book ratio was 5.1× on Nov 11, 2026, against 5.3× a year earlier. Over the last 5 years it ranged from 1.6× to 19.8×, with a median of 4.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.1× | −2.9 |
| 2025 | Dec 31, 2025 | 8.0× | +0.5 |
| 2024 | Dec 31, 2024 | 7.5× | +2.7 |
| 2023 | Dec 29, 2023 | 4.8× | +0.2 |
| 2022 | Dec 30, 2022 | 4.6× | +2.0 |
| 2021 | Dec 31, 2021 | 2.5× | – |
See a number that looks wrong?